Skip to main content
Erschienen in: Supportive Care in Cancer 1/2015

01.01.2015 | Original Article

Clinical implications of malnutrition in childhood cancer patients—infections and mortality

verfasst von: E. A. H. Loeffen, A. Brinksma, K. G. E. Miedema, G. H. de Bock, W. J. E. Tissing

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In childhood cancer patients, malnutrition has been proposed to increase infection rates and reduce survival. We investigated whether malnutrition at diagnosis and during treatment and weight loss during treatment are prognostic factors for infection rates and survival, within a heterogeneous childhood cancer population.

Methods

From two previous studies, all children ≤18 years of age diagnosed with cancer between October 2004 and October 2011 were included in this study. Data regarding BMI, infections, and survival were retrieved. Patients with a BMI z-score lower than −2.0 were classified as malnourished. Weight loss more than 5 % was considered relevant.

Results

Two hundred sixty-nine childhood cancer patients were included in this study. At diagnosis, 5.2 % of all patients were malnourished. These patients showed worse survival than those who were well nourished (hazard ratio (HR) = 3.63, 95 % confidence interval (CI) = 1.52–8.70, p = 0.004). Malnourishment at 3 months after diagnosis (3.3 % of all patients) also showed worse survival (HR = 6.34, 95 % CI = 2.42–16.65, p < 0.001). Weight loss of more than 5 % in the first 3 months after diagnosis was related to increased occurrence of febrile neutropenic episodes with bacteremia in the first year after diagnosis (odds ratio (OR) = 3.05, 95 % CI = 1.27–7.30, p = 0.012).

Conclusion

We found that malnourishment in the initial phase of therapy is associated with worse survival in childhood cancer patients. In addition, we found for the first time that weight loss during treatment is associated with increased presence of febrile neutropenic episodes with bacteremia. This underlines the importance of optimal feeding designs in childhood cancer patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Freycon F, Trombert-Paviot B, Casagranda L, Bertrand Y, Plantaz D, Marec-Berard P (2008) Trends in treatment-related deaths (TRDs) in childhood cancer and leukemia over time: a follow-up of patients included in the childhood cancer registry of the Rhone-Alpes region in France (ARCERRA). Pediatr Blood Cancer 50(6):1213–1220PubMedCrossRef Freycon F, Trombert-Paviot B, Casagranda L, Bertrand Y, Plantaz D, Marec-Berard P (2008) Trends in treatment-related deaths (TRDs) in childhood cancer and leukemia over time: a follow-up of patients included in the childhood cancer registry of the Rhone-Alpes region in France (ARCERRA). Pediatr Blood Cancer 50(6):1213–1220PubMedCrossRef
3.
4.
Zurück zum Zitat Lange BJ, Gerbing RB, Feusner J et al (2005) Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 293(2):203–211PubMedCrossRef Lange BJ, Gerbing RB, Feusner J et al (2005) Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 293(2):203–211PubMedCrossRef
5.
Zurück zum Zitat Cunningham-Rundles S, McNeeley DF, Moon A (2005) Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol 115(6):1119–1129PubMedCrossRef Cunningham-Rundles S, McNeeley DF, Moon A (2005) Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol 115(6):1119–1129PubMedCrossRef
7.
Zurück zum Zitat Lobato-Mendizabal E, Lopez-Martinez B, Ruiz-Arguelles GJ (2003) A critical review of the prognostic value of the nutritional status at diagnosis in the outcome of therapy of children with acute lymphoblastic leukemia. Rev Invest Clin 55(1):31–35PubMed Lobato-Mendizabal E, Lopez-Martinez B, Ruiz-Arguelles GJ (2003) A critical review of the prognostic value of the nutritional status at diagnosis in the outcome of therapy of children with acute lymphoblastic leukemia. Rev Invest Clin 55(1):31–35PubMed
8.
Zurück zum Zitat Butturini AM, Dorey FJ, Lange BJ et al (2007) Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol 25(15):2063–2069PubMedCrossRef Butturini AM, Dorey FJ, Lange BJ et al (2007) Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol 25(15):2063–2069PubMedCrossRef
9.
Zurück zum Zitat Murry DJ, Riva L, Poplack DG (1998) Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl 11:48–51PubMedCrossRef Murry DJ, Riva L, Poplack DG (1998) Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl 11:48–51PubMedCrossRef
10.
Zurück zum Zitat Brinksma A, Huizinga G, Sulkers E, Kamps W, Roodbol P, Tissing W (2012) Malnutrition in childhood cancer patients: a review on its prevalence and possible causes. Crit Rev Oncol Hematol 83(2):249–275PubMedCrossRef Brinksma A, Huizinga G, Sulkers E, Kamps W, Roodbol P, Tissing W (2012) Malnutrition in childhood cancer patients: a review on its prevalence and possible causes. Crit Rev Oncol Hematol 83(2):249–275PubMedCrossRef
11.
Zurück zum Zitat Oude Nijhuis C, Kamps WA, Daenen SM et al (2005) Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol 23(30):7437–7444PubMedCrossRef Oude Nijhuis C, Kamps WA, Daenen SM et al (2005) Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol 23(30):7437–7444PubMedCrossRef
12.
Zurück zum Zitat Miedema KG, de Bont ES, Oude Nijhuis CS, van Vliet D, Kamps WA, Tissing WJ (2011) Validation of a new risk assessment model for predicting adverse events in children with fever and chemotherapy-induced neutropenia. J Clin Oncol 29(7):e182–e184PubMedCrossRef Miedema KG, de Bont ES, Oude Nijhuis CS, van Vliet D, Kamps WA, Tissing WJ (2011) Validation of a new risk assessment model for predicting adverse events in children with fever and chemotherapy-induced neutropenia. J Clin Oncol 29(7):e182–e184PubMedCrossRef
13.
Zurück zum Zitat Stratton RJ, Green CJ, Elia M (2003) Disease related malnutrition, an evidence based approach to treatment, 1st edn. CABI Publishing, Wallingford Stratton RJ, Green CJ, Elia M (2003) Disease related malnutrition, an evidence based approach to treatment, 1st edn. CABI Publishing, Wallingford
14.
Zurück zum Zitat Kazak AE, Hocking MC, Ittenbach RF et al (2012) A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment. Pediatr Blood Cancer 59(1):96–99PubMedCentralPubMedCrossRef Kazak AE, Hocking MC, Ittenbach RF et al (2012) A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment. Pediatr Blood Cancer 59(1):96–99PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53(282):457–481CrossRef Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53(282):457–481CrossRef
16.
Zurück zum Zitat Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163–170PubMed Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163–170PubMed
17.
Zurück zum Zitat Cox D (1972) Regression models and life tables. J R Stat Soc 34(2):187–220 Cox D (1972) Regression models and life tables. J R Stat Soc 34(2):187–220
18.
Zurück zum Zitat Burke ME, Lyden ER, Meza JL, Ladas EJ, Dasgupta R, Wiegner EA, Arndt CA (2013) Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. Pediatr Blood Cancer 60(5):748–753PubMedCrossRef Burke ME, Lyden ER, Meza JL, Ladas EJ, Dasgupta R, Wiegner EA, Arndt CA (2013) Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. Pediatr Blood Cancer 60(5):748–753PubMedCrossRef
19.
Zurück zum Zitat Inaba H, Surprise HC, Pounds S, et al (2012) Effect of body mass index on the outcome of children with acute myeloid leukemia. Cancer Inaba H, Surprise HC, Pounds S, et al (2012) Effect of body mass index on the outcome of children with acute myeloid leukemia. Cancer
20.
Zurück zum Zitat Reilly JJ (1998) Assessment of body composition in infants and children. Nutrition 14(10):821–825PubMedCrossRef Reilly JJ (1998) Assessment of body composition in infants and children. Nutrition 14(10):821–825PubMedCrossRef
21.
Zurück zum Zitat Sala A, Rossi E, Antillon F et al (2012) Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: a perspective from Central America. Eur J Cancer 48(2):243–252PubMedCrossRef Sala A, Rossi E, Antillon F et al (2012) Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: a perspective from Central America. Eur J Cancer 48(2):243–252PubMedCrossRef
22.
Zurück zum Zitat Blum D, Omlin A, Baracos VE, Solheim TS, Tan BH, Stone P et al (2011) Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol 80(1):114–144PubMedCrossRef Blum D, Omlin A, Baracos VE, Solheim TS, Tan BH, Stone P et al (2011) Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol 80(1):114–144PubMedCrossRef
Metadaten
Titel
Clinical implications of malnutrition in childhood cancer patients—infections and mortality
verfasst von
E. A. H. Loeffen
A. Brinksma
K. G. E. Miedema
G. H. de Bock
W. J. E. Tissing
Publikationsdatum
01.01.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2350-9

Weitere Artikel der Ausgabe 1/2015

Supportive Care in Cancer 1/2015 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.